Michelle Parker

Board Director

Director

CU6

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 1 saleMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€671k

Latest filing published 22 Apr 2026 for CU6, €2. Read the official filing

Filing timeline

BuySale

Michelle Parker

Michelle Parker: trading record in brief

Michelle Parker has a single filing on record, published on 22 April 2026: an open-market sale of €671k in Clarity Pharmaceuticals Ltd. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Companies and markets linked to Michelle Parker

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

CU6 (AU)

Declarations1 total

▼

Michelle Parker

DirectorExecutives20 Apr 2026CU6

3 AUD19ASX ↗

360,896 shares@ A$0.000.0000% mcap100.0% of flowShareASXASX:2924-03081425-2A1667765

1 of 1 declaration

Michelle Parker

Michelle Parker: trading record in brief

Companies and markets linked to Michelle Parker

Related entities

Michelle Parker

Michelle Parker: trading record in brief

Companies and markets linked to Michelle Parker

Related entities